|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of Torisel (temsirolimus), Hycamtin (topotecan hydrochloride), and Velcade
(bortezomib) that can be given, in combination, to patients with advanced
cancer that has spread or is unable to be surgically removed. The safety of
this drug combination will also be studied.